Morningstar - Visa Inc. Class A (V) Scharf Steps Down at Visa

Report

Morningstar

Jim Sinegal

EUR 147.86 For Business Accounts Only

Scharf Steps Down at Visa

Visa announced that Charlie Scharf will resign as CEO effective Dec. 1, to be replaced by current board member Alfred Kelly. Scharf had been with Visa since 2012, and according to the company's filing, chose to resign in order to spend less time in San Francisco. Â
Alfred Kelly spent more than 20 years at American Express and currently sits on the Visa board of directors. He has served as the CEO of Intersection, a company attempting to bring wireless Internet to New York, since February 2016. H...

17/10/2016 12 EN

Underlying

Visa Inc. Class A

Visa is engaged in digital payments. The company facilitates payments between consumers and businesses. The company is focused on its proprietary network, VisaNet, to provide products and services. The company provides a portfolio of business payment solutions, including small business, corporate (travel) cards, purchasing cards, virtual cards/digital credentials, non-card cross-border business-to-business payment options and disbursement accounts, covering various main industry segments around the world. The company also provides several capabilities and services, including fraud prevention and security, processing, loyalty, merchant and digital solutions, consulting and data solutions.

See profile

US92826C8394 New York Stock Exchange United States

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Jim Sinegal

Other Reports on these Companies

GSBR Research Pvt Ltd

Global Fintech Industry May 2025

This report looks at the global fintech industry. Fintech as an industry involves the use of technology to compete with traditional financial institutions in the delivery of financial services. Fintech is an emerging industry whose applications are employed in a range of traditional industries. The report talks about the overall market size, expected growth rates as well current trends driving the growth in the industry. Companies can also be categorized as core and non-core, the former being those that exclusively engage in fintech and those for which fintech is just one part of their overall...

EUR 88.17

May 6, 2025 May 6, 2025 56 EN

GSBR Research Pvt Ltd

Visa Inc. Financial Factsheet - Growth, Valuation and Peer Comps

The report gives a detailed financial and operational snapshot of Visa Inc. as of Q2 FY25, based on company filings and independent analysis. It also lists most relevant peer group and their valuation vis-a-vis Visa Inc.

May 2, 2025 May 2, 2025 2 EN

Vermilion Research

Vermilion Macro Vision: Sector Synopsis

STRATEGY Market dynamics remain risk-on, and our outlook remains bullish as long as the S&P 500 remains above 5850 and 5600-5670. Shorter-term, the S&P 500 remains above the prior bull flag support (currently 5900) that we have discussed over the past two weeks in our Compass reports, and is coiling for a likely breakout above 6100 resistance. As discussed throughout the first half of January in our Compass reports, we continue to believe that tariffs will mostly be used as a negotiation tactic, and much like Trump's prior presidency, will be much less impactful than feared. Now, after the t...

EUR 89.06

February 12, 2025 February 12, 2025 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Scharf Steps Down at Visa

Global Fintech Industry May 2025

Visa Inc. Financial Factsheet - Growth, Valuation and Peer Comps

Vermilion Macro Vision: Sector Synopsis

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe